Ready to challenge GlaxoSmithKline and Merck, India's Bharat Biotech has won WHO prequalification for its rotavirus vaccine Rotavac. The designation means international agencies can purchase the cheaper vaccine for use in developing countries, expanding access around the globe.Original Article
Bharat Biotech’s Rotavac, a discounted option to GSK and Merck vaccines, picks up WHO prequalification
